Login to Your Account



Mersana, Endo Shake Hands on $270M ADC Collaboration

By Catherine Shaffer
Staff Writer

Thursday, March 8, 2012
Mersana Therapeutics Inc. is cashing in on the rage for antibody-drug conjugates (ADCs) in a new collaboration agreement with Endo Pharmaceuticals Inc.

To continue reading subscribe now to BioWorld Today

Learn More about BioWorld Today

Already a subscriber? Sign In or Buy now to activate your subscription